204 related articles for article (PubMed ID: 31120925)
1. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R
PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925
[TBL] [Abstract][Full Text] [Related]
2. Computational Study of Novel Natural Inhibitors Targeting O
Yang L; Li W; Zhao Y; Zhong S; Wang X; Jiang S; Cheng Y; Xu H; Zhao G
World Neurosurg; 2019 Oct; 130():e294-e306. PubMed ID: 31203065
[TBL] [Abstract][Full Text] [Related]
3. Computational study on natural compounds inhibitor of c-Myc.
Ren J; Huangfu Y; Ge J; Wu B; Li W; Wang X; Zhao L
Medicine (Baltimore); 2020 Dec; 99(50):e23342. PubMed ID: 33327259
[TBL] [Abstract][Full Text] [Related]
4. Computational study of novel natural inhibitors targeting aminopeptidase N(CD13).
Ge J; Wang Z; Cheng Y; Ren J; Wu B; Li W; Wang X; Su X; Liu Z
Aging (Albany NY); 2020 May; 12(9):8523-8535. PubMed ID: 32388498
[TBL] [Abstract][Full Text] [Related]
5. Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study.
Zhong S; Wu B; Yang W; Ge J; Zhang X; Chen Z; Duan H; He Z; Liu Y; Wang H; Jiang Y; Zhang Z; Wang X; Li W; Liu N; Guo X; Mou Y
Aging (Albany NY); 2021 Jan; 13(2):1898-1912. PubMed ID: 33486472
[TBL] [Abstract][Full Text] [Related]
6. Novel natural inhibitors targeting B-RAF(V600E) by computational study.
Wu B; Zhang Z; Dou G; Lv X; Ge J; Wang H; Xie H; Zhu D
Bioengineered; 2021 Dec; 12(1):2970-2983. PubMed ID: 34252351
[TBL] [Abstract][Full Text] [Related]
7. Computational study on novel natural inhibitors targeting c-MET.
Hou Y; Xie H; Dou G; Yang W; Ge J; Zhou B; Ren J; Li J; Wang J; Zhang Z; Wang X
Medicine (Baltimore); 2021 Sep; 100(38):e27171. PubMed ID: 34559105
[TBL] [Abstract][Full Text] [Related]
8. Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9.
Zhao Y; Li W; Li W; Tao H; Li Y; Wu B; Wang X; Zhou H; Gao B
Biomed Res Int; 2022; 2022():9039377. PubMed ID: 36267835
[TBL] [Abstract][Full Text] [Related]
9. New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high-grade glioma therapy.
Yang W; Wang S; Zhang X; Sun H; Zhang M; Chen H; Cui J; Li J; Peng F; Zhu M; Yu B; Li Y; Yang L; Min W; Xue M; Pan L; Zhu H; Wu B; Gu Y
Front Neurosci; 2022; 16():1060012. PubMed ID: 36685223
[TBL] [Abstract][Full Text] [Related]
10. Computational study on novel natural inhibitors targeting BCL2.
Lv X; Jiang Y; Wang X; Xie H; Dou G; Wang J; Yang W; Wang H; Li Z; Zhang X; Chen Z
Med Oncol; 2021 Jul; 38(8):94. PubMed ID: 34259934
[TBL] [Abstract][Full Text] [Related]
11. Novel natural inhibitors targeting KRAS G12C by computational study.
Jiang Y; Chen W; Wang X; Zhou B; Xie H; Hou Y; Guo Z; Yu B; Zhong S; Su X
Anticancer Drugs; 2022 Oct; 33(9):779-788. PubMed ID: 35980001
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.
Xi Q; Wang M; Jia W; Yang M; Hu J; Jin J; Chen X; Yin D; Wang X
J Med Chem; 2020 Jan; 63(1):260-282. PubMed ID: 31820985
[TBL] [Abstract][Full Text] [Related]
13. Computational study on new natural compound agonists of dopamine receptor.
Li H; Yang W; Xi J; Wang Z; Lu H; Du Z; Li W; Wu B; Jiang S; Peng Y; Liu J; Liu L; Zhang X; Feng J
Aging (Albany NY); 2021 Jun; 13(12):16620-16636. PubMed ID: 34170848
[TBL] [Abstract][Full Text] [Related]
14. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation.
Shukla R; Chetri PB; Sonkar A; Pakharukova MY; Mordvinov VA; Tripathi T
J Biomol Struct Dyn; 2018 Oct; 36(13):3541-3556. PubMed ID: 29029597
[TBL] [Abstract][Full Text] [Related]
16. Design of amidobenzimidazole STING receptor agonists with systemic activity.
Ramanjulu JM; Pesiridis GS; Yang J; Concha N; Singhaus R; Zhang SY; Tran JL; Moore P; Lehmann S; Eberl HC; Muelbaier M; Schneck JL; Clemens J; Adam M; Mehlmann J; Romano J; Morales A; Kang J; Leister L; Graybill TL; Charnley AK; Ye G; Nevins N; Behnia K; Wolf AI; Kasparcova V; Nurse K; Wang L; Puhl AC; Li Y; Klein M; Hopson CB; Guss J; Bantscheff M; Bergamini G; Reilly MA; Lian Y; Duffy KJ; Adams J; Foley KP; Gough PJ; Marquis RW; Smothers J; Hoos A; Bertin J
Nature; 2018 Dec; 564(7736):439-443. PubMed ID: 30405246
[TBL] [Abstract][Full Text] [Related]
17. Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.
Zhou X; Yu S; Su J; Sun L
Int J Mol Sci; 2016 Mar; 17(3):340. PubMed ID: 26959013
[TBL] [Abstract][Full Text] [Related]
18. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
19. Effective natural inhibitors targeting IGF-1R by computational study.
Wang X; Zhou P; Lin L; Wu B; Fu Z; Huang X; Zhu D
Aging (Albany NY); 2022 Jun; 14(11):4874-4887. PubMed ID: 35680570
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
